Aurobindo Pharma reported 24.59B in Operating Expenses for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Cipla CIPLA:IN 41.86B 594.6M
Dr.Reddys Laboratories DRRD:IN 47.14B 6.43B
Hindustan Unilever HUVR:IN IR 95550M 4490M
Sun Pharmaceuticals SUNP:IN IR 70342.1M 2921.2M
UPL UPLL:IN 73.82B 4.93B